Zalman life science
Loading..
Loading..
Showing 1–5 of 5 results
Rabizal-IT Capsules combine rabeprazole sodium, a proton pump inhibitor that reduces stomach acid production, with itopride, a prokinetic agent that enhances gastrointestinal motility. This combination is used in the treatment of gastroesophageal reflux disease (GERD), functional dyspepsia, and other acid-related gastrointestinal conditions, providing dual relief by suppressing acid and improving gastric emptying.
Peantadom-DSR Capsules contain pantoprazole sodium, a proton pump inhibitor that suppresses gastric acid secretion, and domperidone, a prokinetic agent that enhances gastrointestinal motility. This combination is indicated for the treatment of gastroesophageal reflux disease (GERD), dyspepsia, and other acid-related gastrointestinal disorders, offering both acid suppression and relief from nausea or bloating.
Pantozal-LSR Capsules combine pantoprazole sodium, a proton pump inhibitor that reduces gastric acid secretion, with levosulpiride, a prokinetic agent that enhances gastric emptying and intestinal motility. This combination is used for the management of gastroesophageal reflux disease (GERD), functional dyspepsia, and related gastrointestinal disorders, providing both acid suppression and motility regulation.
Pantozal-DSR Capsules combine pantoprazole, a proton pump inhibitor that reduces stomach acid production, with domperidone, a prokinetic agent that enhances gastric motility. This dual-action formulation is indicated for treating gastroesophageal reflux disease (GERD), acidity, and symptoms such as nausea, vomiting.
Omi-ZD Capsules combine omeprazole, a proton pump inhibitor that reduces stomach acid, with domperidone, a prokinetic agent that enhances gastric motility. This combination is used to manage gastroesophageal reflux disease (GERD), acidity, and related symptoms such as nausea and bloating, promoting both acid control and improved digestion.
